Hyaluronic acid oligosaccharide composition and preparation method and use thereof
The hyaluronic acid oligosaccharide compositions prepared by enzymatic reactions, especially tetrasaccharides, hexaoses and octasaccharides, solved the problem that the prior art failed to effectively promote the production of type III and type IV collagens, significantly Improves the anti-aging effect of the skin.
Patent Information
- Application Number
- CN202211676342.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-26
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2042-12-26
AI Technical Summary
The prior art fails to effectively utilize ultra-low molecular weight hyaluronic acid with N-acetylglucosamine as the reducing end to promote the production of type III and type IV collagen, which makes skin aging difficult to solve.
Provided is a hyaluronic acid oligosaccharide composition, which prepares a hyaluronic acid oligosaccharide with a weight average molecular weight less than or equal to 1 kD by enzymatic reaction, and contains hyaluronic acid oligosaccharides of different molecular weights, especially hyaluronic acid tetrasaccharides and hexa sugars. and octasaccharides are used to promote the production of type III and type IV collagen in dermal fibroblasts.
It significantly promotes the production of collagen in the dermis, reduces wrinkles, has certain anti-aging activities, and is suitable for cosmetics and medical devices.
Smart Images

Figure QLYQS_1 
Figure BDA0004018369840000021 
Figure BDA0004018369840000041
Abstract
Description
Technical Field
[0001] The present application belongs to the field of bioengineering technology, and specifically, relates to a hyaluronic acid oligosaccharide composition and a preparation method thereof, as well as the use of the hyaluronic acid oligosaccharide composition in promoting the production of type III and type IV collagen. Background Art
[0002] Hyaluronic acid (HA) is an important component of the human body. It is a high molecular weight acidic mucopolysaccharide with no branching structure, which is composed of N-acetylglucosamine (GlcNAc) and D-glucuronic acid (GlcA) disaccharide repeating units through β-1,4-glycosidic bonds and β-1,3-glycosidic bonds. It is widely distributed in the interstitial cells of animal tissues and the capsules of some bacteria. Studies have found that the physiological effects of HA are closely related to its molecular weight. The smaller the molecular weight, the higher the biological activity.
[0003] The enzymatic method for preparing hyaluronic acid oligosaccharides has strong specificity and can specifically degrade chemical bonds without affecting other molecular groups. Uniform hyaluronic acid of different molecular weights can be obtained by controlling the amount of enzyme added and the reaction time. It also has the advantages of mild reaction and good repeatability. Therefore, the enzymatic method is the most ideal method for preparing low molecular weight hyaluronic acid. According to different sources, catalytic mechanisms, and substrate and product specificity, HAase can be divided into three categories. The three enzymes have different structures and different products. The first type is HA lyase (EC 4.2.2.1), which is mainly found in bacteria, bacteriophages and fungi. It cleaves the β-1,4-glycosidic bond of HA through a β-elimination reaction to produce an unsaturated disaccharide molecule with N-acetylglucosamine at the reducing end; the second type is endo-β-glucuronidase (EC 3.2.1.36), which is mainly found in leeches. It hydrolyzes the β-1,3-glycosidic bond of HA to obtain a product mainly composed of a tetrasaccharide molecule HA with a uronic acid structure at the reducing end; the third type is endo-β-N-acetylglucosamidase (EC 3.2.1.35), which is mainly found in mammals and the venom of bees, snakes, spiders, etc. It can hydrolyze the β-1,4-glycosidic bond of HA to obtain a product mainly composed of a saturated tetrasaccharide HA molecule with N-acetylglucosamine at the reducing end.
[0004] Type III collagen is the main structure of the micro-collagen layer, which can support the epidermis and prevent skin collapse. Type IV collagen is the most important structure of the basement membrane. The skin basement membrane is located between the dermis and the epidermis, and is composed of a variety of extracellular matrix proteins, which firmly connect the dermis and the epidermis. The growth period of skin tissue ends at about 25 years old, after which fibroblasts decrease and the amount of collagen synthesis gradually decreases, the vitality of skin tissue decreases, the elasticity of the skin is gradually lost, the saturation and glossiness of the skin decrease, and a series of skin problems gradually occur. In the prior art, there is no research on the ultra-low molecular weight saturated hyaluronic acid with N-acetylglucosamine as the reducing end to improve skin aging, such as promoting the production of type III and type IV collagen. Summary of the invention
[0005] In view of the problems existing in the prior art, the present application provides a use of a hyaluronic acid oligosaccharide composition in promoting the production of type III and type IV collagen.
[0006] Specifically, this application involves the following aspects:
[0007] 1. A hyaluronic acid oligosaccharide composition, comprising a hyaluronic acid oligosaccharide having a structure shown in formula (I), wherein the reducing end of the hyaluronic acid oligosaccharide is N-acetylglucose:
[0008]
[0009] wherein X is selected from H, K, Na, Ca or Zn;
[0010] n is a positive integer selected from 1-4;
[0011] The weight average molecular weight of the hyaluronic acid oligosaccharide composition is less than or equal to 1 kD, and the hyaluronic acid oligosaccharide composition contains at least two types of hyaluronic acid oligosaccharides.
[0012] 2. According to the hyaluronic acid oligosaccharide composition described in item 1, in the hyaluronic acid oligosaccharide composition, the mass proportion of hyaluronic acid oligosaccharides with n=2 is 55-80%, the mass proportion of hyaluronic acid oligosaccharides with n=1 is 1-10%, the mass proportion of hyaluronic acid oligosaccharides with n=3 is 5-35%, and the mass proportion of hyaluronic acid oligosaccharides with n=4 is 1-10%.
[0013] 3. According to the hyaluronic acid oligosaccharide composition described in item 1, in the hyaluronic acid oligosaccharide composition, the mass proportion of hyaluronic acid oligosaccharides with n=2 is 60-75%, the mass proportion of hyaluronic acid oligosaccharides with n=1 is 1-10%, the mass proportion of hyaluronic acid oligosaccharides with n=3 is 15-30%, and the mass proportion of hyaluronic acid oligosaccharides with n=4 is 1-8%.
[0014] 4. According to the hyaluronic acid oligosaccharide composition of item 1, the mass concentration of the hyaluronic acid oligosaccharide composition in the cosmetic or pharmaceutical product is 0.01%-5%, and more preferably 0.05%-1%.
[0015] 5. A method for preparing the hyaluronic acid oligosaccharide composition according to any one of items 1 to 4, the preparation method comprising the following steps:
[0016] The hyaluronic acid is enzymatically hydrolyzed with hyaluronidase.
[0017] separating the enzymatic reaction product to obtain a hyaluronic acid oligosaccharide composition,
[0018] Wherein, the hyaluronidase is endo-β-N-acetylglucosaminidase,
[0019] Preferably, the hyaluronidase is the mountain ant hyaluronan hydrolase expressed by Pichia pastoris engineered bacteria.
[0020] 6. The method according to claim 5,
[0021] In the enzymatic hydrolysis reaction, the initial concentration of the hyaluronic acid is 40-100 g / L.
[0022] Preferably, the initial enzyme activity of the hyaluronidase is 1.8×10 5 -2.5×10 5 U / mL,
[0023] It is further preferred that the enzymatic hydrolysis reaction temperature is 30-50°C, more preferably 37-45°C.
[0024] 7. Use of the hyaluronic acid oligosaccharide composition described in any one of items 1 to 4 in promoting the production of type III and / or type IV collagen.
[0025] The reducing end of the hyaluronic acid oligosaccharide of the present application is N-acetylglucosamine, which can significantly promote the production of collagen in dermal fibroblasts, especially the production of type III and type IV collagen in fibroblasts, thereby increasing the collagen content in the dermis and reducing the formation of wrinkles. It has certain anti-aging activity and has important application prospects in the field of skin care products and medical devices. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 is a liquid phase diagram of a hyaluronic acid oligosaccharide composition;
[0027] Figure 2 The ion intensity diagrams are for hyaluronan disaccharide (HA2), hyaluronan tetrasaccharide (HA4), hyaluronan hexasaccharide (HA6), and hyaluronan octasaccharide (HA8);
[0028] Figure 3 This is the result of the activity test of human primary dermal fibroblasts;
[0029] Figure 4 RNA-seq results of collagen synthesis genes COL1A1, COL3A1, COL4A1, and COL4A2 in human primary dermal fibroblasts;
[0030] Figure 5 is the content of collagen secreted by fibroblasts after using the hyaluronic acid oligosaccharide composition sample;
[0031] Figure 6 The figure is the immunofluorescence staining of type III collagen of cells after using the hyaluronic acid oligosaccharide composition sample. DETAILED DESCRIPTION
[0032] The present application is further described below in conjunction with examples. It should be understood that the examples are only used to further describe and illustrate the present application and are not used to limit the present application.
[0033] Unless otherwise defined, the technical and scientific terms in this specification have the same meaning as those generally understood by those skilled in the art. Although similar or identical methods and materials as described herein may be used in experiments or practical applications, materials and methods are described herein below. In the event of a conflict, the present specification including the definitions therein shall prevail. In addition, materials, methods and examples are provided for illustration only and are not restrictive. The present application is further described below in conjunction with specific embodiments, but is not intended to limit the scope of the present application.
[0034] Human skin ages naturally with age (endogenous aging) or due to environmental stimulation (exogenous aging), which is manifested by the loss of skin collagen, fine wrinkles, decreased elasticity, sagging skin, etc. If the skin is not well maintained, it will seriously affect beauty.
[0035] In order to solve the problem of skin aging, the present application provides a hyaluronic acid oligosaccharide composition, characterized in that the hyaluronic acid oligosaccharide composition comprises a hyaluronic acid oligosaccharide having a structure shown in formula (I), wherein the reducing end of the hyaluronic acid oligosaccharide is N-acetylglucose:
[0036]
[0037] wherein X is selected from H, K, Na, Ca or Zn;
[0038] n is an integer selected from 1 to 4;
[0039] The hyaluronic acid oligosaccharide composition contains at least two kinds of hyaluronic acid oligosaccharides.
[0040] The mass proportion of hyaluronic acid oligosaccharides with n=2 is 55-80%, the mass proportion of hyaluronic acid oligosaccharides with n=1 is 1-10%, the mass proportion of hyaluronic acid oligosaccharides with n=3 is 5-35%, and the mass proportion of hyaluronic acid oligosaccharides with n=4 is 1-10%.
[0041] Hyaluronic acid oligosaccharides or hyaluronic acid oligosaccharides (oligo-HA) are oligosaccharides with a molecular weight of 10 4 A hyaluronic acid molecule fragment with a monosaccharide residue number of 2 to 25 (generally 4 to 16) and a size below Da. Oligo-HA is a small molecule polysaccharide, and its properties are very different from those of ordinary hyaluronic acid. Studies have shown that oligo-HA has biological activities such as antioxidant, immunomodulatory, anti-inflammatory, wound healing, angiogenesis, and anti-tumor. More importantly, because of its small molecule, it can penetrate into the stratum corneum of the skin to exert deep moisturizing and nourishing effects, and can be widely used in cosmetics.
[0042] When n=1, the hyaluronic acid oligosaccharide is a disaccharide, when n=2, the hyaluronic acid oligosaccharide is a tetrasaccharide, when n=3, the hyaluronic acid oligosaccharide is a hexasaccharide, and when n=4, the hyaluronic acid oligosaccharide is an octasaccharide. Therefore, in the hyaluronic acid oligosaccharide composition of the present application, the mass proportion of tetrasaccharide is 55-80%; the mass proportion of disaccharide is 1-10%; the mass proportion of hexasaccharide is 5-35%; and the mass proportion of octasaccharide is 1-10%.
[0043] Among them, the mass proportion of hyaluronic acid tetrasaccharide is 55-80%, for example, it can be 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80% or any range therebetween.
[0044] Among them, the mass proportion of hyaluronic acid disaccharide is 1-10%, for example, it can be 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, 9.5%, 10.0% or any range therebetween.
[0045] Among them, the mass proportion of hyaluronic acid hexasaccharide is 5-35%, for example, it can be 5.0%, 5.5%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, 9.5%, 10.0%, 11.0%, 12.0%, 13.0%, 14.0%, 15.0%, 16.0%, 17.0%, 18.0%, 19.0%, 20.0%, 21.0%, 22.0%, 23.0%, 24.0%, 25.0%, 26.0%, 27.0%, 28.0%, 29.0%, 30.0%, 31.0%, 32.0%, 33.0%, 34.0%, 35.0% or any range therebetween.
[0046] Among them, the mass proportion of hyaluronic acid octasaccharide is 1-10%, for example, it can be 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, 9.5%, 10.0% or any range therebetween.
[0047] In some embodiments of the present application, in the hyaluronic acid oligosaccharide composition, the mass proportion of hyaluronic acid oligosaccharides with n=2 is 60-75%, the mass proportion of hyaluronic acid oligosaccharides with n=1 is 1-10%, the mass proportion of hyaluronic acid oligosaccharides with n=3 is 15-30%, and the mass proportion of hyaluronic acid oligosaccharides with n=4 is 1-8%.
[0048] In some embodiments of the present application, the weight average molecular weight of the hyaluronic acid oligosaccharide composition is less than or equal to 1 kDa, for example, it can be 1 kDa, 990 Da, 980 Da, 970 Da, 960 Da, 950 Da, 940 Da, 930 Da, 920 Da, 910 Da, 900 Da, 890 Da, 880 Da, 870 Da, 860 Da, 850 Da, 840 Da, 830 Da, 820 Da, 810 Da, 800 Da, 790 Da, 780 Da, 770 Da, 760 Da, 750 Da, 740 Da, 730 Da, 720 Da, 710 Da, 700 Da.
[0049] In some embodiments of the present application, the hyaluronic acid oligosaccharide composition is used in cosmetics or medical products, preferably in the cosmetics or medical products, the mass concentration is 0.01%-5%, more preferably 0.05%-1%; for example, the mass concentration of the hyaluronic acid oligosaccharide composition in the cosmetics or health products can be 0.01%, 0.05%, 0.1%, 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0% or any range therebetween. The mass concentration of the hyaluronic acid oligosaccharide composition in cosmetics or medical products can be further adjusted according to the different uses of the hyaluronic acid oligosaccharide composition in cosmetics or medical products.
[0050] The present application also provides a method for preparing the above-mentioned hyaluronic acid oligosaccharide composition, the preparation method comprising the following steps: subjecting hyaluronic acid to an enzymatic hydrolysis reaction with hyaluronidase, separating the enzymatic hydrolysis reactants to obtain a product stock solution, concentrating the product stock solution to obtain a product concentrate; removing impurities in the product concentrate, filtering, and obtaining a hyaluronic acid oligosaccharide composition, wherein the hyaluronidase is endo-β-N-acetylglucosaminidase,
[0051] Preferably, the hyaluronidase is a hyaluronan hydrolase from the mountain ant expressed by Pichia pastoris engineered bacteria.
[0052] Further preferably, the separation is ultrafiltration;
[0053] Further preferably, the concentration is nanofiltration;
[0054] More preferably, activated carbon adsorption is used to remove impurities.
[0055] The hyaluronidase used in the preparation method is endo-β-N-acetylglucosaminidase, which ensures that the reducing end of the hyaluronic acid oligosaccharide is N-acetylglucose.
[0056] In a specific embodiment, the hyaluronidase is a hyaluronan hydrolase from the mountain ant expressed by Pichia pastoris. For details, see the method described in patent document CN 103695448 A.
[0057] Ultrafiltration is a membrane separation technology that can purify, separate or concentrate solutions. Generally speaking, the pore size of ultrafiltration membranes is between 0.05μm-1nm, and the operating pressure is 0.1-0.5Mpa. It is mainly used to intercept and remove macromolecular substances such as suspended matter, colloids, particles, bacteria and viruses in water. Ultrafiltration membranes can be divided into organic membranes and inorganic membranes according to the membrane material. According to the appearance of the membrane, it can be divided into: flat plate type, tubular type, capillary type, hollow fiber and porous type.
[0058] Nanofiltration is a pressure-driven membrane separation process between reverse osmosis and ultrafiltration. The pore size of the nanofiltration membrane is in the range of several nanometers. Nanofiltration is used to separate substances with relatively small molecular weight, such as inorganic salts or small molecular organic substances such as glucose and sucrose, from solvents. Nanofiltration, also known as low-pressure reverse osmosis, is an emerging field of membrane separation technology. Its separation performance is between reverse osmosis and ultrafiltration, allowing some inorganic salts and certain solvents to pass through the membrane, thereby achieving the separation effect.
[0059] By controlling the conditions of the enzymatic hydrolysis reaction, such as the amount of substrate and enzyme, the molecular weight of the substrate, the reaction temperature and reaction time, as well as the different types of membranes used in ultrafiltration, nanofiltration and filtration, hyaluronic acid oligosaccharide compositions with different molecular weights and different oligosaccharide proportions can be obtained.
[0060] In the enzymatic hydrolysis reaction, the initial concentration of the hyaluronic acid is 40-100 g / L, preferably, the molecular weight of the hyaluronic acid is 1000-3000 kDa, and more preferably, the initial enzymatic activity of the hyaluronidase is 1.8×10 5 -2.5×10 5 U / mL;
[0061] For example, in the enzymatic hydrolysis reaction, the initial concentration of the hyaluronic acid can be 40g / L, 41g / L, 42g / L, 43g / L, 44g / L, 45g / L, 46g / L, 47g / L, 48g / L, 49g / L, 50g / L, 51g / L, 52g / L, 53g / L, 54g / L, 55g / L, 56g / L, 57g / L, 58g / L, 59g / L, 60g / L, 61g / L, 62g / L, 63g / L, 64g / L, 65g / L, 66g / L, 67g / L, 68g / L, 69g / L, 70g / L, 71g / L, 72g / L 9g / L, 70g / L, 71g / L, 72g / L, 73g / L, 74g / L, 75g / L, 76g / L, 77g / L, 78g / L, 79g / L, 80g / L, 81g / L, 82g / L, 83g / L, 84g / L, 85g / L, 86g / L, 87g / L, 88g / L, 89g / L, 90g / L, 91g / L, 92g / L, 93g / L, 94g / L, 95g / L, 96g / L, 97g / L, 98g / L, 99g / L, 100g / L or any range therebetween;
[0062] In the enzymatic hydrolysis reaction, the molecular weight of the hyaluronic acid can be 1000 kDa, 1100 kDa, 1200 kDa, 1300 kDa, 100 kDa, 1600 kDa, 1700 kDa, 1800 kDa, 1900 kDa, 2000 kDa, 2100 kDa, 2200 kDa, 2300 kDa, 2400 kDa, 2500 kDa, 2600 kDa, 2700 kDa, 2800 kDa, 2900 kDa, 3000 kDa or any range therebetween;
[0063] In the enzymatic hydrolysis reaction, the initial enzymatic activity of the hyaluronidase can be 1.8×10 5 U / mL, 1.9×10 5 U / mL, 2.0×10 5 U / mL, 2.1×10 5 U / mL, 2.2×10 5 U / mL, 2.3×10 5 U / mL, 2.4×10 5 U / mL, 2.5×10 5 U / mL or any range therebetween.
[0064] In the present application, a hyaluronidase activity unit (U) is defined as the amount of enzyme required to release 1 μg of reducing sugar equivalent of glucose from hyaluronic acid sugar chains per hour at pH 5.5 and 38°C.
[0065] In some embodiments of the present application, ultrafiltration uses an ultrafiltration membrane with a molecular weight cutoff of 2000-4000Da, nanofiltration uses a nanofiltration membrane with a molecular weight cutoff of 200-500Da, and filtration uses a microporous membrane with a pore size of 0.1-0.45μm;
[0066] For example, the molecular weight cutoff of the ultrafiltration membrane can be 2000 Da, 2100 Da, 2200 Da, 2300 Da, 2400 Da, 2500 Da, 2600 Da, 2700 Da, 2800 Da, 2900 Da, 3000 Da, 3100 Da, 3200 Da, 3300 Da, 3400 Da, 3500 Da, 3600 Da, 3700 Da, 3800 Da, 3900 Da, 4000 Da or any range therebetween;
[0067] The molecular weight cut-off of the nanofiltration membrane can be 200Da, 210Da, 220Da, 230Da, 240Da, 250Da, 260Da, 270Da, 280Da, 290Da, 300Da, 310Da, 320Da, 330Da, 340Da, 350Da, 360Da, 370Da, 380Da, 390Da, 400Da or any range therebetween;
[0068] The pore size of the microporous filter membrane can be 0.1 μm, 0.15 μm, 0.22 μm, 0.25 μm, 0.3 μm, 0.35 μm, 0.4 μm, 0.45 μm or any range therebetween.
[0069] In some embodiments of the present application, in the enzymatic hydrolysis reaction, the temperature of the enzymatic hydrolysis reaction is 30-50°C, preferably 37-45°C, and the time of the enzymatic hydrolysis reaction is 12-48h;
[0070] For example, the temperature of the enzymatic hydrolysis reaction can be 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, 40°C, 41°C, 42°C, 43°C, 44°C, 45°C, 46°C, 47°C, 48°C, 49°C, 50°C or any range therebetween;
[0071] The time of enzymolysis reaction can be 12h, 13h, 14h, 15h, 16h, 17h, 18h, 19h, 20h, 21h, 22h, 23h, 24h, 25h, 26h, 27h, 28h, 29h, 30h, 31h, 32h, 33h, 34h, 35h, 36h, 37h, 38h, 39h, 40h, 41h, 42h, 43h, 44h, 45h, 46h, 47h, 48h or any range therebetween. Molecular weight cut-off described in the present application is the interception performance of the ultrafiltration membrane represented by using molecular weight size, is also called molecular weight cut-off. Due to the considerable difficulty of directly measuring the pore size of ultrafiltration membrane or nanofiltration membrane, the spherical substance of known molecular weight is used to measure. If the retention rate of the membrane for the retained substance is greater than 90%, the molecular weight of the retained substance is used to express the retention performance of the membrane, which is called the molecular weight cut-off of the membrane. For example, a membrane with a molecular weight cut-off of 10kDa can retain substances with a molecular weight greater than 10kDa, while allowing substances with a molecular weight less than 10kDa to pass through.
[0072] The drying in the method can be carried out by various drying methods in the prior art. In a specific embodiment, the drying is spray drying. The air inlet temperature used in the spray drying is 120°C-160°C, and the air outlet temperature is 60°C-80°C;
[0073] For example, the inlet air temperature used in the spray drying is 120°C, 121°C, 122°C, 123°C, 124°C, 125°C, 126°C, 127°C, 128°C, 129°C, 130°C, 131°C, 132°C, 133°C, 134°C, 135°C, 136°C, 137°C, 138°C, 139°C, 140°C, 141°C, 142°C, 143°C, 144°C, 145°C, 146°C, 147°C, 148°C, 149°C, 150°C, 151°C, 152°C, 153°C, 154°C, 155°C, 156°C, 157°C, 158°C, 159°C, 160°C or any range therebetween;
[0074] The air outlet temperature may be 60°C, 61°C, 62°C, 63°C, 64°C, 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C or any range therebetween. Further, the hyaluronic acid oligosaccharide composition obtained by the method is the above-mentioned hyaluronic acid oligosaccharide composition, i.e., the hyaluronic acid oligosaccharide having the structure shown in formula (I):
[0075]
[0076] Wherein, n is an integer selected from 1-4, and X is selected from H, K, Na, Ca or Zn, preferably Na.
[0077] Among them, the identification of various oligosaccharides in the hyaluronic acid oligosaccharide product can be detected by mass spectrometry, the content of various oligosaccharides can be detected by high performance liquid chromatography, and the weight average molecular weight of the hyaluronic acid oligosaccharide product can be calculated by the peak response values and theoretical molecular weights of various oligosaccharides.
[0078] The causes of skin aging are mainly reflected in the following aspects: 1. Changes in the extracellular matrix of the dermis. Collagen is the main component of the extracellular matrix of the dermis, accounting for about 90% of the protein in the human dermis. The protein in the dermis is mainly composed of type I collagen (80%) and a small amount of type III collagen (10%). Collagen gives the skin strength and elasticity. With age, the number of collagen fibers in the skin decreases, causing the skin to lose elasticity and produce wrinkles. 2. Changes in the structure of the basement membrane zone. Type IV collagen is the main component of the dense layer of the basement membrane zone, which tightly connects the dermis and the epidermis. With age, type IV collagen is lost, the structure of the basement membrane zone loosens, and the wrinkles become flat, and the cell connections become sparse, which reduces the efficiency of material exchange between the dermis and the epidermis. This leads to insufficient nutrition in the epidermis, and the epidermal cells cannot proliferate and differentiate normally. This in turn causes the epidermis to become thinner and loosen.
[0079] In view of the main causes of skin aging mentioned above, the present application provides the use of the above-mentioned hyaluronic acid oligosaccharide composition in promoting the production of type III and type IV collagen.
[0080] In some embodiments of the present application, the above-mentioned hyaluronic acid oligosaccharide composition is used in anti-skin aging; preferably, the above-mentioned hyaluronic acid oligosaccharide composition resists skin aging by promoting the production of type III and type IV collagen.
[0081] Regarding the hyaluronic acid oligosaccharide composition, please refer to the above description of the hyaluronic acid oligosaccharide composition, which will not be repeated here.
[0082] In some embodiments of the present application, the hyaluronic acid oligosaccharide composition is applied to the skin. Preferably, the application to the skin is through cosmetics or medical devices.
[0083] In some embodiments of the present application, the mass concentration of the hyaluronic acid oligosaccharide composition in the cosmetic or medical device is 0.01%-5%, preferably 0.05%-1%; for example, it can be 0.01%, 0.05%, 0.1%, 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0% or any range therebetween.
[0084] In some embodiments of the present application, the above-mentioned hyaluronic acid oligosaccharide composition is used to promote the production of type III and type IV collagen.
[0085] Regarding the hyaluronic acid oligosaccharide composition, please refer to the above description of the hyaluronic acid oligosaccharide composition, which will not be repeated here.
[0086] Example
[0087] Example 1 Preparation of hyaluronic acid oligosaccharide composition
[0088] 3.6×10 8 U hyaluronidase (the enzyme is recombinant mountain giant ant venom hyaluronidase, the preparation method refers to the description method in patent document CN114350691A), system enzyme activity 1.8×10 5U / mL, add 50mM sodium acetate, adjust the pH to 5.5 with acetic acid, and the reaction system is 2L. Add 4% high molecular weight hyaluronic acid (molecular weight 1000-1300kDa), stir and dissolve at 37°C for 24h, and collect the filtrate by microfiltration. Ultrafiltration with a 3000Da organic membrane is used to collect the permeate. The retained concentrate is first heat-treated for 30min to completely inactivate the residual enzyme, treated with activated carbon, and then filtered with a 0.22um filter membrane. Spray drying is carried out under the conditions of an inlet air temperature of 150°C, an outlet air temperature of 70°C, and a pump speed of 25mL / min to obtain a hyaluronic acid oligosaccharide composition powder with a reducing end of N-acetylglucose.
[0089] The hyaluronic acid oligosaccharide composition was analyzed for its oligosaccharide distribution using a high performance liquid chromatograph, and the specific chromatographic conditions were as follows:
[0090] Column: Superdex TM 75Increase 10 / 300GL
[0091] Detector: UV-Vis spectrophotometer
[0092] Mobile phase: 5 mM ammonium acetate solution
[0093] Injection concentration: 1.0g / L
[0094] Injection volume: 20 μL
[0095] Flow rate: 0.3mL / min
[0096] Detection wavelength: 200nm
[0097] The results are as follows Figure 1 As shown, in the hyaluronic acid oligosaccharide composition, the mass proportion of hyaluronic acid oligodisaccharide is 3.36%, the mass proportion of hyaluronic acid oligotetrasaccharide is 68.95%, the mass proportion of hyaluronic acid oligohexasaccharide is 25.41%, and the mass proportion of hyaluronic acid oligooctasaccharide is 2.27%.
[0098] The weight average molecular weight calculation formula of the hyaluronic acid oligosaccharide composition is shown in the following formula I:
[0099] Formula II:
[0100] Wherein: ru1 is the peak response value of hyaluronic acid octasaccharide in the sample solution, and Mw1 is the molecular weight of hyaluronic acid octasaccharide; ru2 is the peak response value of hyaluronic acid hexasaccharide in the sample solution, and Mw2 is the molecular weight of hyaluronic acid hexasaccharide; ru3 is the peak response value of hyaluronic acid tetrasaccharide in the sample solution, and Mw3 is the molecular weight of hyaluronic acid tetrasaccharide; ru4 is the peak response value of hyaluronic acid disaccharide in the sample solution, and Mw4 is the molecular weight of hyaluronic acid disaccharide; rt is the sum of the peak response values of hyaluronic acid octasaccharide, hexasaccharide, tetrasaccharide and disaccharide in the sample solution.
[0101] The theoretical molecular weight of hyaluronic acid disaccharide is 397.1, the theoretical molecular weight of hyaluronic acid tetrasaccharide is 776.1, the theoretical molecular weight of hyaluronic acid hexasaccharide is 1155.2, and the theoretical molecular weight of hyaluronic acid octasaccharide is 1534.3.
[0102] According to formula II, the weight average molecular weight of the hyaluronic acid oligosaccharide composition is 877 Da.
[0103] Example 2 Preparation of hyaluronic acid oligosaccharide composition
[0104] 5.0×10 8 U hyaluronidase (the enzyme is recombinant mountain giant ant venom hyaluronidase, the preparation method refers to the description method in patent document CN114350691A), system enzyme activity 2.5×10 5 U / mL, add 50mM sodium acetate, adjust the pH to 5.5 with acetic acid, and the reaction system is 2L. Add 10% high molecular weight hyaluronic acid (molecular weight 1000-1300kDa), stir and dissolve at 37°C for 24h, and collect the filtrate by microfiltration. Ultrafiltration with 3000Da organic membrane is used to collect the permeate. Retain with 300Da organic membrane nanofiltration, and the retained concentrate is first heat-treated for 30min to completely inactivate the residual enzyme, treated with activated carbon, and then filtered with a 0.22um filter membrane. Spray drying is carried out under the conditions of inlet air temperature of 150°C, outlet air temperature of 70°C, and pump speed of 25mL / min to obtain a hyaluronic acid oligosaccharide composition powder with N-acetylglucose at the reducing end.
[0105] The hyaluronic acid oligosaccharide composition was analyzed for its oligosaccharide distribution using a high performance liquid chromatograph, and the specific chromatographic conditions were the same as those in Example 1.
[0106] In the hyaluronic acid oligosaccharide composition, the mass proportion of hyaluronic acid oligodisaccharide is 3.81%, the mass proportion of hyaluronic acid oligotetrasaccharide is 66.05%, the mass proportion of hyaluronic acid oligohexasaccharide is 25.45%, and the mass proportion of hyaluronic acid oligooctasaccharide is 4.15%.
[0107] According to formula II, the weight average molecular weight of the hyaluronic acid oligosaccharide composition is 885 Da.
[0108] Example 3 Preparation of hyaluronic acid oligosaccharide composition
[0109] 3.6×10 8 U hyaluronidase (the enzyme is recombinant mountain giant ant venom hyaluronidase, the preparation method refers to the description method in patent document CN114350691A), system enzyme activity 1.8×10 5 U / mL, add 50mM sodium acetate, adjust the pH to 5.5 with acetic acid, and the reaction system is 2L. Add 7.5% high molecular weight hyaluronic acid (molecular weight 1000-1300kDa), stir and dissolve at 45°C for 24h, and collect the filtrate by microfiltration. Ultrafiltration with a 3000Da organic membrane is used to collect the permeate. The retained concentrate is first heat-treated for 30min to completely inactivate the residual enzyme, treated with activated carbon, and then filtered with a 0.22um filter membrane. Spray drying is carried out under the conditions of an inlet air temperature of 150°C, an outlet air temperature of 70°C, and a pump speed of 25mL / min to obtain a hyaluronic acid oligosaccharide composition powder with a reducing end of N-acetylglucose.
[0110] The hyaluronic acid oligosaccharide composition was analyzed for its oligosaccharide distribution using a high performance liquid chromatograph, and the specific chromatographic conditions were the same as those in Example 1.
[0111] In the hyaluronic acid oligosaccharide composition, the mass proportion of hyaluronic acid oligodisaccharide is 9.88%, the mass proportion of hyaluronic acid oligotetrasaccharide is 66.6%, the mass proportion of hyaluronic acid oligohexasaccharide is 22.06%, and the mass proportion of hyaluronic acid oligooctasaccharide is 1.46%.
[0112] According to formula II, the weight average molecular weight of the hyaluronic acid oligosaccharide composition is 833 Da.
[0113] Test example
[0114] Test Example 1
[0115] (1) Mass spectrometry
[0116] The hyaluronic acid oligosaccharide composition obtained in Example 1 was analyzed using Shimadzu Corporation's LCMS-IT-TOF liquid spectrometer. 18 The chromatographic column was used, and the mobile phase was acetonitrile and water, with a flow rate of 0.2 mL / min. The acetonitrile concentration was linearly increased to 12% and decreased to 0 after 10 min. The mass spectrometry was performed in negative ion mode, scanning once every 10 s, with an m / z range of 100-1500. Multistage mass spectrometry analysis was performed under the same operating conditions.
[0117] The results are as follows Figure 2 As shown, the mass peak at 1.83min on the mass spectrometer total ion current peak graph is in negative ion mode [MH]- was 396.11, identified as hyaluronan disaccharide ( Figure 2 a); The mass peaks at 3.75min and 4.05min on the mass spectrometer total ion current peak graph are in negative ion mode [MH] - was 775.22, identified as hyaluronan tetrasaccharide ( Figure 2 b); The mass peaks at 5.15min and 5.40min on the mass spectrometer total ion current peak graph are in negative ion mode [MH] - 1154.33, [MH] 2- was 576.66, identified as hyaluronan hexasaccharide ( Figure 2 c); The mass peak at 6.30 min on the mass spectrometer total ion current peak graph is in negative ion mode [MH] 2- was 766.21, identified as hyaluronic acid octasaccharide ( Figure 2 (d)
[0118] (2) Identification of reducing ends of hyaluronic acid oligosaccharide compositions
[0119] The reducing end of the hyaluronic acid oligosaccharide composition obtained in Examples 1-3 was identified.
[0120] The reducing end of the hyaluronic acid oligosaccharide composition was determined by colorimetry using the Morgan-Elson reaction. If it turns red, it indicates that the reducing end is N-acetylglucosamine, and if it does not turn red, it indicates that the reducing end is uronic acid.
[0121] Reaction buffer: alkaline borate solution (dissolve 1.73 g H3BO3 and 0.78 g KOH in 10 mL water, add one tenth of its volume 0.8 g ml -1 K2CO3), p-dimethylaminobenzaldehyde solution (dissolve 2g p-dimethylaminobenzaldehyde solution in 2.5mL concentrated hydrochloric acid and 7.5mL glacial acetic acid, and dilute 4 times with glacial acetic acid before use).
[0122] Take 400 μL of 10 g / L hyaluronic acid oligosaccharide composition solution, add it to 110 μL alkaline borate solution, mix thoroughly, boil for 4 min, add 1.5 mL of p-dimethylaminobenzaldehyde, mix thoroughly, and incubate at 37° C. for 20 min.
[0123] Hydrolyzed sodium hyaluronate (molecular weight 1000Da, Bloomage Biotechnology Co., Ltd., refer to patent document CN113801904A, reducing end is uronic acid) and hyaluronic acid tetrasaccharide (HA4, purchased from Sigma, reducing end is N-acetylglucosamine) solutions were used as controls.
[0124] The results are shown in Table 1. The hyaluronic acid oligosaccharide compositions prepared in Examples 1-3 turned red after the Moran-Elson reaction, proving that the reducing end was N-acetylglucose.
[0125] Table 1
[0126]
[0127] Test Example 2 Activity test of human primary dermal fibroblasts
[0128] Human primary dermal fibroblasts were cultured in 5% CO2 and 37°C culture conditions using fibroblast culture medium. When the cells grew to 80-90% confluence, they were digested with trypsin and inoculated in 96-well plates. After the cells were attached and cultured in 96-well plates for 48 hours, samples of hyaluronic acid oligosaccharide compositions of different mass concentrations were prepared to treat the cells (N=3). The mass concentrations of the hyaluronic acid oligosaccharide compositions were 5%, 2%, 1%, 0.5%, 0.2%, 0.1%, 0.05%, 0.02%, and 0.01%, respectively. In addition, the control group (NT) was not treated with the hyaluronic acid oligosaccharide composition. After 48 hours, CCK-8 reagent was added and incubated for 1 hour according to the instructions, and the OD value was read at 450nm with an ELISA reader. The relative cell activity value was obtained by calculating the ratio of the average OD values of the sample group and the control group (NT) to determine the cytotoxic effect of the sample.
[0129] Relative cell activity % = (OD value of sample group / OD value of control group) × 100%
[0130] The results are as follows Figure 3 The hyaluronic acid oligosaccharide composition has no cytotoxic effect within the mass concentration range of 0.01%-5%.
[0131] Experimental Example 3 Transcriptome Sequencing and Data Analysis of Human Primary Dermal Fibroblasts
[0132] When the fibroblasts cultured in vitro grow to 80-90% confluence, they are digested with trypsin and inoculated into 12-well plates. After the cells were attached and cultured in 12-well plates for 48 hours, the fibroblasts were starved overnight using a serum-free starvation medium to synchronize the growth of the cell population, and then the cells were treated with a hyaluronic acid oligosaccharide composition sample (N=3) prepared with a starvation medium at a mass concentration of 0.1%, and the control group (NT) was not treated with a hyaluronic acid oligosaccharide composition sample. After 24 hours, the supernatant was aspirated, Trizol reagent was added to each well, the cells were digested and lysed by blowing thoroughly, and the lysate was transferred to -80°C for storage. After the total RNA extraction quality inspection was qualified, the library was constructed, and the samples were subjected to high-throughput sequencing using the double-end sequencing mode of the Illumina Hiseq sequencing platform.
[0133] Type I collagen is composed of two α1(I) chains (encoded by COL1A1) and one α2(I) chain intertwined. Type III collagen is composed of three identical α1(III) chains and is encoded by COL3A1. Type IV collagen is assembled from six α chains and has three different heterotrimers: α1α1α2(IV), α5α5α6(IV), and α3α4α5(IV). The first two are mainly found in skin tissue. COL4A1 encodes the α1(IV) chain and COL4A2 encodes the α2(IV) chain. Figure 4 Compared with the blank control, the expression of COL1A1, COL3A1, COL4A1, and COL4A2 was significantly upregulated after dermal fibroblasts were treated with 0.1% hyaluronic acid oligosaccharide composition.
[0134] Test Example 4: Test of collagen production in human primary dermal fibroblasts
[0135] When the fibroblasts cultured in vitro grow to 80-90% confluence, they are digested with trypsin and inoculated in 96-well plates. After the cells are attached and cultured in 96-well plates for 48h, the fibroblasts are starved overnight using a serum-free starvation medium to synchronize the growth of the cell colony, and then the hyaluronic acid oligosaccharide composition samples (N=3) of different mass concentrations are prepared with starvation medium to treat the cells, and the mass concentration of the hyaluronic acid oligosaccharide composition samples is 0.5%, 0.2%, 0.1%, 0.05%, 0.02%, 0.01%. The treatment group containing 10ng / mL TNF-α is set as the positive control group at the same time. The blank control group (NT) is not used for the treatment of hyaluronic acid oligosaccharide composition. After 48h, the cell culture supernatant is taken for the ELISA test of type I collagen and type III collagen, and the collagen content of the measured sample group is statistically compared with the blank control group (NT) to evaluate the influence of the hyaluronic acid oligosaccharide composition on the amount of collagen production.
[0136] The statistical results are as follows Figure 5 As shown in FIG. 1 , the hyaluronic acid oligosaccharide composition has a significant promoting effect on the production of type I collagen by fibroblasts only at a relatively narrow effective concentration (0.05%) (p<0.05). Figure 5 a, while the hyaluronic acid oligosaccharide composition has a significant promoting effect on the production of type III collagen in fibroblasts within a wide effective concentration range (0.02%-0.5%) (p<0.05), which is more than 20% higher than that of the blank control group (NT). Figure 5b. Patent document CN113876623A discloses the use of a hyaluronic acid oligosaccharide composition in anti-skin aging, wherein the hyaluronic acid oligosaccharide composition comprises hyaluronic acid oligosaccharides with a uronic acid structure at the reducing end, which has a significant promoting effect on type I collagen. This indicates that different structures of hyaluronic acid oligosaccharides have different effects.
[0137] Test Example 5III Collagen Immunofluorescence Staining
[0138] When the fibroblasts cultured in vitro grow to 80-90% confluence, they are digested with trypsin; TC-treated cell slides are placed in 12-well plates, and then the fibroblast suspension is inoculated on the cell slides. After the cells are attached to the slides for 48 hours, they are starved overnight with serum-free starvation medium to synchronize the growth of the cell population, and then the cells are treated with hyaluronic acid oligosaccharide samples (N=3) with a mass concentration of 0.1% prepared with starvation medium, and the treatment group containing 10ng / mL TNF-α is set as the positive control group. After 48 hours of treatment, the cell culture supernatant is aspirated, the cell slides are rinsed twice with DPBS, and then the slides are fixed with paraformaldehyde fixative for at least 30 minutes. Immunofluorescence staining was performed on the cell slides. The cells were permeabilized with 0.5% Triton X-100 for 10 minutes and blocked with 5% BSA for 1 hour. Anti-Collagen III primary antibody was added for 90 minutes, followed by Goat Anti-Rabbit IgG (H+L) secondary antibody for 60 minutes, and DAPI counterstained the cell nucleus for 30 minutes. The slides were sealed and stored in the dark. Microscopic cell fluorescence images were taken using an upright fluorescence microscope.
[0139] like Figure 6 The blue fluorescence is the cell nucleus, and the red fluorescence is the collagen. The results show that the hyaluronic acid oligosaccharide composition with a mass concentration of 0.1% has a significant promoting effect on the production of type III collagen in fibroblasts.
Claims
1. A hyaluronic acid oligosaccharide composition, characterized in that: The hyaluronic acid oligosaccharide composition comprises a hyaluronic acid oligosaccharide having a structure shown in formula (I), wherein the reducing end of the hyaluronic acid oligosaccharide is N-acetylglucose: Formula (I) wherein X is selected from H, K, Na, Ca or Zn; n is a positive integer selected from 1-4; The weight average molecular weight of the hyaluronic acid oligosaccharide composition is less than or equal to 1 kD; In the hyaluronic acid oligosaccharide composition, the mass proportion of hyaluronic acid oligosaccharides with n=2 is 60-75%, the mass proportion of hyaluronic acid oligosaccharides with n=1 is 1-10%, the mass proportion of hyaluronic acid oligosaccharides with n=3 is 15-30%, and the mass proportion of hyaluronic acid oligosaccharides with n=4 is 1-8%.
2. The hyaluronic acid oligosaccharide composition according to claim 1, characterized in that The mass concentration of the hyaluronic acid oligosaccharide composition in cosmetics or medical devices is 0.01%-5%.
3. The hyaluronic acid oligosaccharide composition according to claim 2, characterized in that The mass concentration of the hyaluronic acid oligosaccharide composition in cosmetics or medical devices is 0.05%-1%.
4. A method for preparing a hyaluronic acid oligosaccharide composition as claimed in any one of claims 1 to 3, characterized in that: The preparation method comprises the following steps: The hyaluronic acid is enzymatically hydrolyzed with hyaluronidase. separating the enzymatic reaction product to obtain a hyaluronic acid oligosaccharide composition, Wherein, the hyaluronidase is endo-β-N-acetylglucosaminidase.
5. The method according to claim 4, characterized in that The hyaluronidase is a hyaluronan hydrolase from the mountain ant expressed by Pichia pastoris engineered bacteria.
6. The method according to claim 5, characterized in that In the enzymatic hydrolysis reaction, the initial concentration of the hyaluronic acid is 40-100 g / L.
7. The method according to claim 6, characterized in that The initial enzyme activity of the hyaluronidase was 1.8×10 5 -2.5×10 5 U / mL.
8. The method according to claim 6, characterized in that The enzymatic hydrolysis reaction temperature is 30-50°C.
9. The method according to claim 8, characterized in that The enzymatic hydrolysis reaction temperature is 37-45°C.
10. Use of the hyaluronic acid oligosaccharide composition according to any one of claims 1 to 3 in the preparation of a product that promotes the production of type III and / or type IV collagen.
